We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
|Bid||24.00 x 900|
|Ask||24.42 x 1100|
|Day's Range||24.14 - 24.71|
|52 Week Range||19.71 - 40.12|
|Beta (5Y Monthly)||1.04|
|PE Ratio (TTM)||42.10|
|Earnings Date||Feb 08, 2024 - Feb 12, 2024|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||26.27|
Subscribe to Yahoo Finance Plus to view Fair Value for DOCS
Telehealth stocks were all the rage during the pandemic, with many expecting the valuations of these companies to soar due to people staying home and practicing social distancing. However, as the old normal returned, some investors cast doubt over the long-term viability of telehealth stocks. The truth is this: The pandemic was a black swan event and a catalyst that sent the stock prices of telehealth stock soaring, but it didn’t change the long-term secular trends of the industries in which the
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...
Doximity, Inc. (NYSE:DOCS) Q2 2024 Earnings Call Transcript November 9, 2023 Doximity, Inc. beats earnings expectations. Reported EPS is $0.22, expectations were $0.18. Operator: Good afternoon. My name is Krista and I’ll be your conference operator today. At this time, I would like to welcome everyone to the Doximity’s Fiscal Second Quarter 2024 Earnings Call. […]
Plug Power raises 'substantial doubt about its ability to continue as a going concern' and the stock plunges, Trade Desk falls sharply after its outlook for the fourth quarter is shy of Wall Street estimates, and Illumina slumps on weak guidance.
Shares of healthcare professional network Doximity (NYSE:DOCS) jumped 29% in the morning session after the company reported a classic "beat and raise" quarter that investors love. Third quarter results beat Wall Street's expectations for revenue and handily beat expectations for Adjusted EBITDA and EPS. Additionally, it was good to see Doximity's optimistic revenue and adjusted EBITDA guidance for the next quarter, which exceeded analysts' expectations. Lastly, revenue and adjusted EBITDA guidan
The online platform for medical professionals also reported fiscal second-quarter adjusted earnings that beat analysts' estimates.
Although the revenue and EPS for Doximity (DOCS) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Healthcare professional network Doximity (NYSE:DOCS) reported Q2 FY2024 results beating Wall Street analysts' expectations, with revenue up 11.2% year on year to $113.6 million. On top of that, next quarter's revenue guidance ($127.5 million at the midpoint) was surprisingly good and 3.6% above what analysts were expecting. Turning to EPS, Doximity made a GAAP profit of $0.15 per share, improving from its profit of $0.12 per share in the same quarter last year.
SAN FRANCISCO, November 09, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2024 second quarter ended September 30, 2023.
|Symbol||Last Price||Change||% Change|
DigitalOcean Holdings, Inc.
Global-e Online Ltd.
|Symbol||Last Price||Change||% Change|
Veeva Systems Inc.
Teladoc Health, Inc.
GoodRx Holdings, Inc.
10x Genomics, Inc.
|Maintains||Piper Sandler: Neutral to Neutral||11/10/2023|
|Maintains||Morgan Stanley: Underweight to Underweight||11/10/2023|
|Maintains||Canaccord Genuity: Buy to Buy||9/5/2023|
|Maintains||Wells Fargo: Equal-Weight to Equal-Weight||8/11/2023|
|Maintains||Truist Securities: Hold to Hold||8/9/2023|
|Maintains||Morgan Stanley: Underweight to Underweight||8/9/2023|
Industry: Health Information Services
Full Time Employees: 977
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.